Activated clotting time measurements during percutaneous coronary interventions in clinical practice. Results of the ALKK PCI registry

被引：0
|
作者：
Zahn, R.
Zeymer, U.
Mark, B.
Bonzel, T.
Tebbe, U.
Weber, M. A.
Gottwik, M.
Senges, J.
机构：
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [21] Comparison of the i-STAT handheld activated clotting time with the hemochron activated clotting time during and after percutaneous coronary intervention
    Schussler, JM
    Aguanno, JJ
    Glover, EN
    Vish, NA
    Wissinger, LA
    Schumacher, JR
    Wheelan, KR
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (04): : 464 - +
  • [22] Prescription of Direct Oral Anticoagulant Affects Activated Clotting Time During Percutaneous Coronary Intervention and Clinical Outcomes
    Ebihara, Suguru
    Jujo, Kentaro
    Kamishima, Kazuho
    Shimazaki, Kensuke
    Moriyama, Tetsu
    Shiozaki, Natsuko
    Inagaki, Keiko
    Iwanami, Yuji
    Ishida, Issei
    Suzuki, Kazuhito
    Saito, Katsumi
    Hagiwara, Nobuhisa
    CIRCULATION, 2018, 138
  • [23] Are activated clotting time measurements still needed during percutaneous coronary intervention? Ananlysis of 4 randomized clincal trials
    Brener, S
    Moliterno, D
    Lincoff, AM
    Steinhubi, SR
    Wolski, KE
    Topol, EJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 308 - 308
  • [24] Use of bivalirudin during primary PCI in clinical practice: results from the PCI registry of ALLK
    Bauer, T.
    Hochadel, M.
    Hauptmann, K. E.
    Brachmann, J.
    Mudra, H.
    Darius, H.
    Kerber, S.
    Zeymer, U.
    Zahn, R.
    EUROPEAN HEART JOURNAL, 2012, 33 : 474 - 474
  • [25] The association between activated clotting time and hemorrhagic complications in patients undergoing percutaneous coronary interventions with bivalirudin
    Martinez, JM
    Trimino, EM
    Berg, JM
    Anton, MP
    CHEST, 2003, 124 (04) : 150S - 151S
  • [26] Use of prasugrel in Primary percutaneous intervention in Daily Clinical Practice. Results of the Prospective ATACS Registry
    Zeymer, Uwe
    Gitt, Anselm
    Zahn, Ralf
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B17 - B17
  • [27] Activated Clotting Time During Percutaneous Coronary Intervention A Test for All Seasons or a Mind Tranquilizer?
    Ndrepepa, Gjin
    Kastrati, Adnan
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (04)
  • [28] Activated Clotting Time (ACT)-Guided Intravenous Dalteparin Dosing during Percutaneous Coronary Intervention
    Marmur, Jonathan D.
    Poludasu, Shyam
    Feit, Alan
    Battala, Venkata R.
    Cavusoglu, Erdal
    JOURNAL OF INVASIVE CARDIOLOGY, 2008, 20 (07): : 323 - 327
  • [29] Defining the optimal activated clotting time during percutaneous coronary intervention - Aggregate results from 6 randomized, controlled trials
    Chew, DP
    Bhatt, DL
    Lincoff, AM
    Moliterno, DJ
    Brener, SJ
    Wolski, KE
    Topol, EJ
    CIRCULATION, 2001, 103 (07) : 961 - 966
  • [30] The association between activated clotting time and hemorrhagic complications in patients undergoing percutaneous coronary interventions with bivalirudin.
    Trimino, EM
    Berg, JM
    Martinez, JM
    Anton, MP
    PHARMACOTHERAPY, 2003, 23 (10): : 1330 - 1330
12345